Clinical trial reportHematology (Amsterdam, Netherlands)Published
Clinical features and management of GPRC5D-associated adverse events in novel GPRC5D × CD3 bispecific talquetamab-treated relapsed/refractory multiple myeloma patients: the MonumenTAL-1 China cohort experience
Regional connection
Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source
- Institution
- Johnson & Johnson
- County
- Montgomery County
Publication record
- Type
- Clinical trial report
- Venue
- Hematology (Amsterdam, Netherlands)
- Published
- Topic
- Clinical care
- Subject terms
- Humans; Multiple Myeloma; Recurrence; Receptors, G-Protein-Coupled; Antibodies, Bispecific; Cohort Studies; Adult; Aged; Middle Aged; China; Female; Male
- PubMed ID
- 42679119
- Added to directory
- Source checked